Effect of Pyridorin in Patients With Diabetic Nephropathy
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety, tolerability and efficacy of
Pyridorin (pyridoxamine dihydrochloride) up to 250 mg given orally twice daily in patients
with diabetic kidney disease.